Metraipolis › archive › dc_1f71dfd66cca

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? — Europe PMC PMID:42045678

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42045678
DOI: 10.1038/s44321-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-03T04:32:10.820Z
SHA-256 of the archived text: b368f1881417845171cf9935fb73b4fad72984914c955ba9e5d8ed012f7a1dec
Stable URL of this page: https://metraipolis.com/documento/dc_1f71dfd66cca

How to cite

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? — Europe PMC PMID:42045678 — Europe PMC (en), https://europepmc.org/article/MED/42045678 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f71dfd66cca (Metraipolis archive dc_1f71dfd66cca, sha256 b368f1881417845171cf9935fb73b4fad72984914c955ba9e5d8ed012f7a1dec)

BibTeX

@misc{dc1f71dfd66cca,
  title = {Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? — Europe PMC PMID:42045678},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42045678},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f71dfd66cca; sha256 b368f1881417845171cf9935fb73b4fad72984914c955ba9e5d8ed012f7a1dec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42045678. Agents can read the archived copy with the MCP tool read_document.